Atypical hemolytic uremic syndrome with a C3 variant following COVID-19: a case report
Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic microangiopathy (TMA) characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury, and is caused by overactivation of the alternative complement pathway. A 13-year-old Japanese boy with a...
Saved in:
Main Authors: | Masato Ando, Kazuo Kubota, Saori Kadowaki, Minako Kawamoto, Norio Kawamoto, Haruka Okamoto, Soichiro Nagaya, Yuki Miwa, Hidenori Ohnishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1507727/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical Hemolytic Uremic Syndrome with Eosinophilia and Purtscher-like Retinopathy: A Case Report
by: MEI Qimin, et al.
Published: (2024-12-01) -
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01) -
Severe pregnancy-associated atypical hemolytic uremia syndrome in the context of the COVID-19 pandemic: a novel survival case report
by: Yan Yang, et al.
Published: (2025-01-01) -
Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance
by: Santiago Rodríguez de Córdoba, et al.
Published: (2025-01-01) -
Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders
by: Shihan Zhang, et al.
Published: (2025-01-01)